Cargando…
Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market
INTRODUCTION: Sudden unexpected death in epilepsy (SUDEP) is possibly the most common cause of death as a result of complications from epilepsy. The need to educate and regularly review risk for all patients with epilepsy is paramount, but rarely delivered in actual clinical practice. Evidence sugge...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JMIR Publications Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916330/ https://www.ncbi.nlm.nih.gov/pubmed/27269382 http://dx.doi.org/10.2196/resprot.5389 |
_version_ | 1782438814456741888 |
---|---|
author | Newman, Craig Shankar, Rohit Hanna, Jane McLean, Brendan Osland, Alex Milligan, Cathryn Ball, Abbie Jory, Caryn Walker, Matthew |
author_facet | Newman, Craig Shankar, Rohit Hanna, Jane McLean, Brendan Osland, Alex Milligan, Cathryn Ball, Abbie Jory, Caryn Walker, Matthew |
author_sort | Newman, Craig |
collection | PubMed |
description | INTRODUCTION: Sudden unexpected death in epilepsy (SUDEP) is possibly the most common cause of death as a result of complications from epilepsy. The need to educate and regularly review risk for all patients with epilepsy is paramount, but rarely delivered in actual clinical practice. Evidence suggests that education around SUDEP and modifiable risk variables translate into better self-management of epilepsy. OBJECTIVE: We aimed to develop and implement an eHealth solution to support education and self-management of risks, in epilepsy. METHODS: We undertook an innovation pathways approach, including problem identification, feasibility assessment, design, implementation, and marketing. People with epilepsy were provided a smartphone-based app (Epilepsy Self-Monitor, EpSMon), which translates the clinical risk assessment tool into an educational and self-monitoring platform, for the self-management of epilepsy. RESULTS: Results include the success of the marketing campaign, and in what areas, with an estimated reach of approximately 38 million people. EpSMon has proved a success in academic and clinical circles, attracting awards and nominations for awards. The number of users of EpSMon, after 3 months, turned out to be lower than expected (N=221). A 4-month trial of the app in use in the United Kingdom, and the success of the marketing strategy, point to necessary changes to the model of delivery and marketing, summarized in this paper. These include the marketing message, user cost model, and need for the availability of an Android version. CONCLUSIONS: EpSMon has proven a success in respect to its reception by academics, clinicians, stakeholder groups, and the patients who use it. There is work needed to promote the model and increase its acceptability/attractiveness, including broadening the marketing message, increasing its availability, and reducing its cost. Future development and promotion of the tool will hopefully inform iterative design of its core features for a receptive audience and lead to increased uptake as it is launched worldwide in 2016. |
format | Online Article Text |
id | pubmed-4916330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | JMIR Publications Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-49163302016-07-11 Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market Newman, Craig Shankar, Rohit Hanna, Jane McLean, Brendan Osland, Alex Milligan, Cathryn Ball, Abbie Jory, Caryn Walker, Matthew JMIR Res Protoc Original Paper INTRODUCTION: Sudden unexpected death in epilepsy (SUDEP) is possibly the most common cause of death as a result of complications from epilepsy. The need to educate and regularly review risk for all patients with epilepsy is paramount, but rarely delivered in actual clinical practice. Evidence suggests that education around SUDEP and modifiable risk variables translate into better self-management of epilepsy. OBJECTIVE: We aimed to develop and implement an eHealth solution to support education and self-management of risks, in epilepsy. METHODS: We undertook an innovation pathways approach, including problem identification, feasibility assessment, design, implementation, and marketing. People with epilepsy were provided a smartphone-based app (Epilepsy Self-Monitor, EpSMon), which translates the clinical risk assessment tool into an educational and self-monitoring platform, for the self-management of epilepsy. RESULTS: Results include the success of the marketing campaign, and in what areas, with an estimated reach of approximately 38 million people. EpSMon has proved a success in academic and clinical circles, attracting awards and nominations for awards. The number of users of EpSMon, after 3 months, turned out to be lower than expected (N=221). A 4-month trial of the app in use in the United Kingdom, and the success of the marketing strategy, point to necessary changes to the model of delivery and marketing, summarized in this paper. These include the marketing message, user cost model, and need for the availability of an Android version. CONCLUSIONS: EpSMon has proven a success in respect to its reception by academics, clinicians, stakeholder groups, and the patients who use it. There is work needed to promote the model and increase its acceptability/attractiveness, including broadening the marketing message, increasing its availability, and reducing its cost. Future development and promotion of the tool will hopefully inform iterative design of its core features for a receptive audience and lead to increased uptake as it is launched worldwide in 2016. JMIR Publications Inc. 2016-06-07 /pmc/articles/PMC4916330/ /pubmed/27269382 http://dx.doi.org/10.2196/resprot.5389 Text en ©Craig Newman, Rohit Shankar, Jane Hanna, Brendan McLean, Alex Osland, Cathryn Milligan, Abbie Ball, Caryn Jory, Matthew Walker. Originally published in JMIR Research Protocols (http://www.researchprotocols.org), 07.06.2016. https://creativecommons.org/licenses/by/2.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0/ (https://creativecommons.org/licenses/by/2.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Research Protocols, is properly cited. The complete bibliographic information, a link to the original publication on http://www.researchprotocols.org, as well as this copyright and license information must be included. |
spellingShingle | Original Paper Newman, Craig Shankar, Rohit Hanna, Jane McLean, Brendan Osland, Alex Milligan, Cathryn Ball, Abbie Jory, Caryn Walker, Matthew Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market |
title | Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market |
title_full | Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market |
title_fullStr | Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market |
title_full_unstemmed | Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market |
title_short | Developing an Evidence-Based Epilepsy Risk Assessment eHealth Solution: From Concept to Market |
title_sort | developing an evidence-based epilepsy risk assessment ehealth solution: from concept to market |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4916330/ https://www.ncbi.nlm.nih.gov/pubmed/27269382 http://dx.doi.org/10.2196/resprot.5389 |
work_keys_str_mv | AT newmancraig developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT shankarrohit developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT hannajane developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT mcleanbrendan developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT oslandalex developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT milligancathryn developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT ballabbie developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT jorycaryn developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket AT walkermatthew developinganevidencebasedepilepsyriskassessmentehealthsolutionfromconcepttomarket |